Non-Histaminergic Itch Mediators Elevated in the Skin of a Porcine Model of Scabies and of Human Scabies Patients.

[1]  O. Chosidow,et al.  Scabies Itch. , 2018, Dermatologic clinics.

[2]  O. Chosidow,et al.  European guideline for the management of scabies , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  T. Vos,et al.  Global, regional, and national incidence and prevalence, and years lived with disability for 328 diseases and injuries in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017 .

[4]  Hoon-Soo Kim,et al.  Clinical characteristics of pruritus in scabies , 2017, Indian journal of dermatology, venereology and leprology.

[5]  J. Sutra,et al.  Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model , 2016, PLoS neglected tropical diseases.

[6]  G. Yosipovitch,et al.  Advances in understanding itching and scratching: a new era of targeted treatments , 2016, F1000Research.

[7]  C. Chiaverini,et al.  Clinical Phenotype of Scabies by Age , 2014, Pediatrics.

[8]  J. McCarthy,et al.  Treatment and control of scabies. , 2013, Current opinion in infectious diseases.

[9]  U. Hengge,et al.  Acute Morbidity Associated with Scabies and Other Ectoparasitoses Rapidly Improves After Treatment with Ivermectin , 2012, Pediatric dermatology.

[10]  Mei-Fong Ho,et al.  A Tractable Experimental Model for Study of Human and Animal Scabies , 2010, PLoS neglected tropical diseases.

[11]  R. Schwartz,et al.  Scabies: a ubiquitous neglected skin disease. , 2006, The Lancet. Infectious diseases.

[12]  O. Chosidow.  Clinical practices. Scabies. , 2006, The New England journal of medicine.

[13]  J. Heukelbach,et al.  Scabies , 1929, The Lancet.